Filtered By:
Source: American Journal of Health-System Pharmacy : AJHP
Infectious Disease: Hepatitis C
Drug: Warfarin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Increased warfarin requirements in a patient with chronic hepatitis C infection receiving sofosbuvir and ribavirin.
CONCLUSION: A 63-year-old man on a stable dose of warfarin experienced a decrease in INR values after the initiation of a 12-week course of sofosbuvir and ribavirin for the treatment of chronic HCV infection.
PMID: 28596225 [PubMed - in process]
Source: American Journal of Health-System Pharmacy : AJHP - June 11, 2017 Category: Drugs & Pharmacology Authors: Peterson D, Van Ermen A Tags: Am J Health Syst Pharm Source Type: research
